Altamira Therapeutics Ltd (CYTO)
1.53
+0.06
(+4.08%)
USD |
NASDAQ |
May 31, 16:00
1.50
-0.03
(-1.96%)
After-Hours: 20:00
Altamira Therapeutics Enterprise Value: 2.692M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 2.692M |
| May 30, 2024 | 2.558M |
| May 29, 2024 | 2.849M |
| May 28, 2024 | 2.872M |
| May 24, 2024 | 3.252M |
| May 23, 2024 | 3.096M |
| May 22, 2024 | 2.468M |
| May 21, 2024 | 2.580M |
| May 20, 2024 | 2.603M |
| May 17, 2024 | 2.760M |
| May 16, 2024 | 2.760M |
| May 15, 2024 | 2.692M |
| May 14, 2024 | 2.491M |
| May 13, 2024 | 2.491M |
| May 10, 2024 | 2.513M |
| May 09, 2024 | 2.625M |
| May 08, 2024 | 2.558M |
| May 07, 2024 | 2.804M |
| May 06, 2024 | 2.961M |
| May 03, 2024 | 2.939M |
| May 02, 2024 | 2.894M |
| May 01, 2024 | 2.894M |
| April 30, 2024 | 2.782M |
| April 29, 2024 | 2.782M |
| April 26, 2024 | 3.051M |
| Date | Value |
|---|---|
| April 25, 2024 | 2.849M |
| April 24, 2024 | 2.491M |
| April 23, 2024 | 2.804M |
| April 22, 2024 | 2.401M |
| April 19, 2024 | 2.433M |
| April 18, 2024 | 2.625M |
| April 17, 2024 | 2.580M |
| April 16, 2024 | 2.916M |
| April 15, 2024 | 2.984M |
| April 12, 2024 | 3.364M |
| April 11, 2024 | 3.342M |
| April 10, 2024 | 3.745M |
| April 09, 2024 | 3.432M |
| April 08, 2024 | 3.566M |
| April 05, 2024 | 3.633M |
| April 04, 2024 | 3.947M |
| April 03, 2024 | 3.611M |
| April 02, 2024 | 3.857M |
| April 01, 2024 | 3.992M |
| March 28, 2024 | 3.069M |
| March 27, 2024 | 3.584M |
| March 26, 2024 | 3.712M |
| March 25, 2024 | 3.584M |
| March 22, 2024 | 2.444M |
| March 21, 2024 | 2.352M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-1.514M
Minimum
Nov 26 2019
46.99M
Maximum
Mar 09 2021
11.20M
Average
9.348M
Median
Jun 07 2022
Enterprise Value Benchmarks
| Kiniksa Pharmaceuticals Ltd | 1.135B |
| Tiziana Life Sciences Ltd | 100.32M |
| Landos Biopharma Inc (DELISTED) | 42.67M |
| AbbVie Inc | 340.70B |
| Masimo Corp | 7.335B |
Enterprise Value Related Metrics
| Earnings Yield | -1.80K% |
| Normalized Earnings Yield | -1704.43 |